A Drug & Medical Device Recall And/Or Safety Alert Has Been Issued: Hospira Propofol Injectable Emulsion: Recall – Glass Vial Defect. According to the Food & Drug Administration FDA’s MedWatch:
Risks associated with this defect could include tissue necrosis in one or more organs that could result in stroke, myocardial infarction, respiratory failure, and loss of renal and hepatic function.
For more information on the drug or medical device recall or safety alert, read the Food & Drug Administration’s FDA’s drug or medical device recall or safety alert: Hospira Propofol Injectable Emulsion: Recall – Glass Vial Defect.
To report an adverse reaction, problem or other issue with a drug or medical device, submit a drug or medical device complaint to the government at fda.gov or MedWatch.
If you have thoughts on the drug or medical device recall or safety alert, share your drug or medical device recall or safety alert comments below.